These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1105875)

  • 21. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A; Vermylen J; Verstraete M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377
    [No Abstract]   [Full Text] [Related]  

  • 22. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Physiology of hemostasis. II. Fibrinolysis].
    Sultan Y; Caen J; Allain JP; Meyer D
    Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the concentration of streptokinase needed for activation of plasminogen in plasma.
    Nakamura K
    Tokushima J Exp Med; 1978 Dec; 25(3-4):163-8. PubMed ID: 752999
    [No Abstract]   [Full Text] [Related]  

  • 25. Physico-chemical characterization of a human gamma globulin subfraction capable of forming plasminogen activator with streptokinase.
    Doleschel W; Auerswald W
    Med Pharmacol Exp Int J Exp Med; 1966; 14(2):145-51. PubMed ID: 4159755
    [No Abstract]   [Full Text] [Related]  

  • 26. Problems of resistant thrombolysis and early recurrent thrombosis in streptokinase therapy.
    Dhall DP; Dawson AA; Mavor GE
    Surg Gynecol Obstet; 1978 Jan; 146(1):15-20. PubMed ID: 618486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rat plasminogen system, intrahepatic fibrinolysis and carbon tetrachloride hepatotoxicity.
    Innerfield I; Rowley GR; Zwell P; Porpora J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):447-55. PubMed ID: 5590237
    [No Abstract]   [Full Text] [Related]  

  • 28. The sensitivity of rabbit plasminogen to streptokinase in circulating blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1973; 11(3):235-43. PubMed ID: 4778383
    [No Abstract]   [Full Text] [Related]  

  • 29. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of disialic acid-containing glycoproteins in mouse serum: a novel modification of immunoglobulin light chains, vitronectin, and plasminogen.
    Yasukawa Z; Sato C; Sano K; Ogawa H; Kitajima K
    Glycobiology; 2006 Jul; 16(7):651-65. PubMed ID: 16608914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of the 4 thrombus stages on fibrinolysis using streptokinase].
    Gottlob R; Blümel G
    Med Welt; 1968 Nov; 48():2627-43. PubMed ID: 5730608
    [No Abstract]   [Full Text] [Related]  

  • 33. Preparation of a novel streptokinase mutant with improved stability.
    Shi GY; Chang BI; Su SW; Young KC; Wu DH; Chang LC; Tsai YS; Wu HL
    Thromb Haemost; 1998 May; 79(5):992-7. PubMed ID: 9609235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis.
    Leebeek FW; Kluft C; Knot EA; De Maat MP
    J Lab Clin Med; 1989 Apr; 113(4):493-7. PubMed ID: 2703760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
    Spöttl F; Holzknecht F
    Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemical aspects of the streptokinase effect].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):437-44. PubMed ID: 63431
    [No Abstract]   [Full Text] [Related]  

  • 37. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 38. Complete amino acid sequence of canine miniplasminogen.
    Schaller J; Straub C; Kämpfer U; Rickli EE
    Protein Seq Data Anal; 1989 Dec; 2(6):445-50. PubMed ID: 2626424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.